Neuroblastoma Screening (PDQ®)–Patient Version
Neuroblastoma screening does reduce the chance of dying from the disease. Not all screening tests are helpful and most have risks. Learn more about neuroblastoma and the potential benefits and harms of screening in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/2497.htm
- Syndication ID: 19040
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:10 PM
- Date Syndication Updated: Tuesday, October 06, 2020 at 06:02 AM
Tags
General:
screening
patient
version
neuroblastoma
disease screening
Embed Code Snippet
To get the embed code snippet please Login.
